Sudden Vision Changes in AMD: Know When to Act

Understanding Age-Related Macular Degeneration

Understanding Age-Related Macular Degeneration

AMD is a disease of the central retina, and its effects depend on which form is present and how far it has progressed. Knowing the difference between dry and wet AMD helps you understand your risk and what to watch for.

The macula is the small, highly sensitive area at the center of the retina. It gives you the sharp, detailed vision you rely on for reading, recognizing faces, and performing close work. When the macula is damaged, the center of your visual field becomes blurred, distorted, or blank. Your side vision (peripheral vision) typically stays intact, but central vision loss can significantly limit daily activities.

Dry AMD is the more common form and involves the gradual thinning and breakdown of the macula over months or years. Most people with AMD have the dry form. Wet AMD is less common but far more dangerous because it can cause rapid and severe damage within days or even hours. Both forms require monitoring by a retina specialist, but wet AMD demands immediate attention the moment symptoms appear.

Wet AMD occurs when abnormal new blood vessels grow beneath the retina in a process called choroidal neovascularization (CNV). These vessels are fragile and prone to leaking blood and fluid. When fluid pools beneath the macula, it lifts and distorts the photoreceptors, which are the specialized cells that convert light into visual signals sent to the brain. This disruption is what causes the sudden, noticeable vision changes associated with wet AMD.

Most people who develop wet AMD had dry AMD first. About 10 percent of all AMD cases eventually progress to the wet form, according to the American Macular Degeneration Foundation. The risk of conversion increases with each advancing stage of dry AMD, which is why regular monitoring matters even when your condition appears stable. Patients with intermediate or advanced dry AMD carry a meaningfully higher conversion risk than those with early-stage disease.

Who Is at Risk for AMD

Who Is at Risk for AMD

AMD is far more common than many people realize, and certain factors increase the chance of developing it or of progressing from dry to wet AMD. Understanding your personal risk helps you and your retina specialist plan the right monitoring approach.

AMD affects tens of millions of people worldwide. Among Medicare beneficiaries aged 65 and older, approximately 10 percent have some form of AMD, with about 2 percent having the wet form, according to research published by the National Institutes of Health. Globally, AMD is expected to affect approximately 288 million people by 2040, according to the American Macular Degeneration Foundation.

Several factors increase your likelihood of developing AMD or progressing to a more advanced stage. Being aware of these factors allows you and your retina specialist to decide how often your eyes should be monitored.

  • Older age is the strongest risk factor for AMD, with risk rising significantly after age 55.
  • Cigarette smoking is the most significant modifiable risk factor and is directly linked to both developing AMD and converting from dry to wet AMD.
  • A family history of AMD raises your risk, reflecting a genetic component to the disease.
  • Having wet AMD in one eye significantly increases the risk that the other eye may also develop wet AMD.
  • Women and individuals of European descent have been found to have higher rates of conversion from dry to wet AMD.

If you have wet AMD in one eye and dry AMD in the other (called the fellow eye), monitoring that fellow eye closely is critical. Research shows that patients in this situation face a higher risk of conversion than those who have dry AMD in both eyes. Active abnormal blood vessel growth in one eye is associated with a greater likelihood of conversion in the other, making consistent follow-up appointments especially important.

Recognizing the Warning Signs

Wet AMD can develop suddenly and without pain. Knowing what to look for gives you the best chance of getting treatment quickly and preserving your vision.

The following changes in your central vision are warning signs of wet AMD. Any one of these symptoms deserves same-day contact with a retina specialist.

  • Straight lines that look wavy, bent, or distorted. This is often the earliest and most recognizable warning sign.
  • A dark, gray, or blank spot forming in the center of your vision.
  • Sudden blurriness in the center of your visual field that was not present before.
  • Colors that appear faded, washed out, or less vivid than usual.
  • Difficulty reading, recognizing faces, or completing tasks that require sharp central vision.

These symptoms do not cause eye pain. Waiting for pain as a cue to act can result in significant and preventable vision loss.

In wet AMD, the abnormal blood vessels beneath the retina can leak blood or fluid very quickly. This fluid lifts and distorts the macula, disrupting the photoreceptor cells within hours or days. Unlike dry AMD, which typically progresses over months or years, wet AMD can noticeably alter your vision in a very short time. A change that seems minor one morning may become substantially worse by the next day if left unaddressed.

An Amsler grid is a simple tool that looks like graph paper with a small dot at the center. Your retina specialist may recommend checking your vision with this grid every morning. To use it, hold it at reading distance in good lighting, cover one eye, and focus on the center dot. Notice whether any lines look wavy, blurry, distorted, or missing. Then switch eyes and repeat.

If you notice any new distortion or a blank area that was not present the day before, contact a retina specialist that same day. This check takes less than one minute and can help you detect a conversion from dry to wet AMD before significant and permanent damage occurs.

How Wet AMD Is Diagnosed

A prompt evaluation by a retina specialist is the most important first step after noticing a sudden vision change. A thorough examination combined with advanced imaging helps confirm the diagnosis and guide treatment decisions.

If you notice sudden vision changes, your retina specialist will perform a comprehensive dilated eye exam. Dilating drops are placed in the eye to widen the pupil so the specialist can examine the retina in detail. During this exam, the specialist looks for signs of fluid, blood, or abnormal blood vessel activity beneath and within the macula. The examination typically takes less than an hour from start to finish.

Several advanced imaging technologies help confirm the presence of wet AMD, reveal the extent of disease activity, and inform treatment decisions.

  • Optical coherence tomography (OCT) creates detailed cross-sectional images of the retinal layers and can detect even very small amounts of fluid beneath or within the macula. OCT is the primary imaging tool used to monitor AMD at every visit.
  • Fluorescein angiography involves injecting a safe imaging dye into a vein in the arm and photographing the retina as the dye circulates through the blood vessels. This test highlights areas of leakage or abnormal vessel growth.
  • OCT angiography (OCTA) is a newer, noninvasive technique that maps the retinal blood vessel network without the need for a dye injection. It is particularly useful for detecting and characterizing choroidal neovascularization.

Wide-field imaging may also be used to capture a broader view of the retina, giving your specialist a more complete picture of overall retinal health.

Research consistently shows that earlier treatment leads to better visual outcomes in wet AMD. Evidence suggests that beginning treatment within the first 48 hours of symptom onset may preserve more vision than delayed care. Even a delay of a few weeks can allow the abnormal vessels to cause greater and potentially irreversible damage to the macula. If you notice a change in your vision, contact our office the same day rather than waiting for a scheduled appointment.

Treatment for Wet AMD

Treatment for Wet AMD

The goal of treatment is to stop leakage from the abnormal blood vessels, stabilize vision, and in many cases help recover vision that has been affected. Your retina specialist will design a treatment plan based on your specific condition and how your eye responds over time.

The standard and most effective treatment for wet AMD is anti-VEGF injection therapy. VEGF stands for vascular endothelial growth factor, a protein that drives the growth of abnormal blood vessels. Anti-VEGF medications block this protein to stop leakage and may cause the abnormal vessels to shrink. These medications are delivered by intravitreal injection, meaning a small amount of medication is placed directly into the eye.

Anti-VEGF therapy has transformed the treatment of wet AMD. Before these medications became widely available, significant and progressive vision loss from wet AMD was far more common. With consistent, properly timed treatment, many patients are able to stabilize their vision, and some recover visual acuity they had lost.

Several anti-VEGF medications are currently approved and in active use for wet AMD. Each has its own properties and dosing schedule.

  • Eylea (aflibercept) is one of the most widely used agents. After a loading phase of monthly injections, it is typically administered every 4 to 8 weeks based on your response.
  • Eylea HD (high-dose aflibercept) is a higher-dose formulation that allows extended dosing intervals. After loading doses, some patients receive injections every 8 to 16 weeks.
  • Lucentis (ranibizumab) was the first anti-VEGF medication approved specifically for eye conditions and is typically given every 4 weeks.
  • Avastin (bevacizumab) is FDA-approved for cancer treatment and is widely used in ophthalmology as an off-label option for wet AMD, typically every 4 to 6 weeks.
  • Vabysmo (faricimab) is a newer bispecific antibody that targets two pathways involved in wet AMD. Dosing can range from every 4 to 16 weeks depending on how your eye responds.

The choice of medication depends on your individual retinal response, your health history, and your treatment schedule. Your retina specialist will recommend the most appropriate option for your situation.

Most anti-VEGF treatment plans begin with a loading phase of three monthly injections. After this initial period, your retina specialist adjusts the interval between injections based on how your retina is responding. Some patients require monthly injections long term, while others can gradually extend the interval to every two or three months. At each visit, an OCT scan is performed to check for fluid before any dosing decision is made. This individualized approach is commonly called a treat-and-extend protocol.

Wet AMD is a chronic condition. Stopping injections without the guidance of your retina specialist can allow disease activity to return and cause further, preventable vision loss.

Research into new and longer-lasting AMD treatments is actively ongoing. Clinical trials are investigating therapies that may require fewer injections, work through new biological pathways, or offer sustained drug delivery over extended periods. There is also research focused on slowing the progression of dry AMD before it converts to the wet form. Complement inhibitors including Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol) are approved for geographic atrophy, an advanced form of dry AMD, though these medications are not used for wet AMD. Our practice is actively involved in clinical research, and patients interested in emerging treatment options are welcome to ask about clinical trial opportunities at any of our offices.

What to Expect During Treatment

Many patients feel anxious about receiving an eye injection before their first procedure. Understanding what the process involves often eases those concerns considerably. The injection is performed quickly in our office, and most patients find it much more comfortable than they expected.

Before the injection, anesthetic drops are placed in the eye to numb the surface. The eye is then cleaned with an antiseptic solution to reduce infection risk. The injection itself takes only seconds. Most patients feel mild pressure rather than sharp pain during the procedure. Afterward, you may notice a gritty sensation, mild redness, or a small floating bubble in your vision. These effects typically resolve within a day or two.

After each injection, your retina specialist schedules a follow-up visit that includes an OCT scan to check for fluid in the retinal layers. If fluid has resolved and the retina appears stable, the interval between injections may be extended. If fluid returns or increases, the interval may be shortened. This ongoing evaluation ensures that your treatment plan stays aligned with how your eye is responding over time.

Anti-VEGF treatment stabilizes or improves vision in many patients, but outcomes vary from person to person. Some patients recover several lines of vision on an eye chart, while others maintain their current level without further loss. The primary goal is to prevent additional damage to the macula and preserve as much functional vision as possible. Beginning treatment early and attending follow-up appointments consistently gives you the best opportunity for a favorable outcome.

Living Well With AMD

Managing AMD well requires attention both inside and outside the clinic. Daily monitoring, healthy habits, and access to the right support resources can all make a meaningful difference in your quality of life.

If you have been diagnosed with any stage of AMD, checking your vision every day is one of the most important things you can do. Use an Amsler grid each morning, testing each eye separately. If you notice any new distortion, waviness, dark spots, or blurring that was not present the day before, contact a retina specialist right away. Do not wait for your next scheduled appointment. A sudden new change may indicate that wet AMD has developed or that existing wet AMD has become active again.

While no lifestyle change can reverse AMD, certain habits may support retinal health and potentially slow the rate of progression. Your retina specialist can help you determine which steps are most relevant to your specific stage of disease.

  • Quit smoking if you currently smoke. Smoking is the most significant modifiable risk factor for AMD and is directly associated with faster progression and higher rates of wet AMD conversion.
  • Follow a diet rich in leafy green vegetables, colorful fruits, and fatty fish. These foods provide antioxidants and omega-3 fatty acids that may support retinal health.
  • Ask your retina specialist whether AREDS2 vitamin supplements are appropriate for your stage of AMD. These supplements have been shown to reduce the risk of progression in intermediate and certain advanced stages of dry AMD.
  • Wear sunglasses that block UV light when spending time outdoors.
  • Maintain a healthy body weight and stay physically active.

If AMD has affected your central vision, low vision aids and rehabilitation services can help you maintain independence and daily function. Magnifying devices, specialized task lighting, large-print materials, and screen reader technologies are among the tools that can make reading, navigation, and everyday tasks more manageable. Your retina specialist can connect you with a low vision specialist and recommend resources based on your individual needs and the stage of your condition.

When to Seek Urgent Care

When to Seek Urgent Care

Some vision changes are emergencies. Recognizing which symptoms require immediate action can protect your sight in situations where every hour matters.

If you experience any of the following, contact a retina specialist the same day or seek emergency evaluation immediately. Do not wait to see if the symptom improves on its own.

  • A sudden increase in the number of floaters in your vision.
  • Flashes of light, especially in your peripheral (side) vision.
  • A curtain, veil, shadow, or dark area spreading across your visual field.
  • Sudden vision loss in one eye.
  • New distortion of straight lines, particularly if you have already been diagnosed with dry AMD.
  • A new dark or gray spot appearing in the center of your vision.

When wet AMD develops, the abnormal blood vessels beneath the retina can leak blood and fluid rapidly, destroying photoreceptor cells that cannot regenerate once lost. Research supported by the American Macular Degeneration Foundation suggests that the time between symptom onset and treatment may be the single most important factor in determining how much vision can be preserved. Acting at the first sign of a sudden vision change gives you the best possible opportunity to protect your remaining sight.

If you notice a change in your vision and are uncertain whether it warrants urgent care, err on the side of caution. Contact a retina specialist the same day if you can. Describe what you are experiencing, when it started, and which eye is affected. Our practice reserves time for patients with urgent vision concerns, and same-day or next-day appointments are often available. It is always better to have an evaluation that turns out to be routine than to delay assessment of a potentially sight-threatening condition.

Frequently Asked Questions

Here are answers to questions we frequently hear from patients who have been diagnosed with AMD or who have experienced a sudden vision change.

Yes, and this is one of the most important things to understand about the disease. A normal exam result reflects only the state of your retina at that specific moment, not what may happen in the weeks or months that follow. Wet AMD can develop and progress significantly between scheduled appointments, which is precisely why daily home monitoring with an Amsler grid is so valuable. If you detect any new distortion or blank spot, contact a retina specialist right away regardless of when you were last seen.

Many patients with wet AMD require long-term treatment, though the frequency of injections often decreases as the condition stabilizes. Some patients transition from monthly to less frequent visits as their retina responds well over time. Others require consistent monthly care indefinitely. Your retina specialist will determine the right schedule based on your OCT results and clinical response at each visit. Reducing or stopping injections on your own, without medical guidance, risks reactivation of the disease and additional vision loss that may have been prevented.

There is no proven method to fully prevent conversion from dry to wet AMD. That said, quitting smoking is the most impactful action you can take to reduce overall AMD risk. AREDS2 supplements, when recommended by your retina specialist for your specific stage of disease, have been shown to reduce the risk of progression in intermediate and advanced dry AMD. The most important practical step remains daily Amsler grid monitoring, because earlier detection of conversion directly translates to earlier treatment and better outcomes.

Even a delay of a few weeks can result in additional and potentially permanent damage to the macula. The abnormal vessels in wet AMD continue leaking as long as they go untreated, and the photoreceptor cells they destroy cannot be replaced. Studies support the importance of treating wet AMD as early as possible, with evidence suggesting that treatment within the first 48 hours of symptom onset may preserve meaningfully more vision. If you suspect wet AMD has developed, please seek evaluation without delay rather than scheduling a routine appointment at the next available opening.

Most patients are genuinely surprised by how manageable the procedure is. The eye is fully numbed with anesthetic drops before the injection, so sharp pain is not typical. Most patients describe a sensation of mild pressure or brief discomfort lasting only seconds. Some notice a feeling of fullness in the eye immediately afterward, and mild grittiness or redness may last a day or two. The procedure itself is completed very quickly, and the great majority of patients find the experience far less uncomfortable than they anticipated before their first injection.

It is generally advisable to arrange a ride to and from your injection appointment. The dilating drops used during the examination can temporarily blur your vision and increase your sensitivity to bright light, making it unsafe to drive until the effects wear off. This is especially true for patients attending their first appointment, since you will not yet know how your eyes respond to dilation. Our team is happy to walk you through what to expect on the day of your procedure when you schedule your visit.

Expert Retina Care at New England Retina Associates

If you have noticed a sudden change in your central vision, or if you are living with AMD and want dedicated, experienced retina care, we encourage you to reach out to New England Retina Associates. Our fellowship-trained vitreoretinal surgeons provide comprehensive AMD evaluation and treatment at four convenient offices, and we welcome both referred and self-referred patients across Connecticut. As a retina-only practice with an active clinical research program and decades of experience in macular disease, we are committed to delivering current, personalized care for every patient we see. Same-day and urgent appointments are available for those who need immediate attention.

30 Years of Care & Commitment

Google Reviews